vimarsana.com

Wedbush lowered shares of Unity Biotechnology (NASDAQ:UBX – Free Report) from an outperform rating to a neutral rating in a research note released on Monday morning, The Fly reports. Other equities analysts also recently issued reports about the stock. Citigroup lifted their target price on shares of Unity Biotechnology from $5.00 to $6.00 in a […]

Related Keywords

,Virtu Financial ,Schonfeld Strategic Advisors ,Unity Biotechnology Inc ,Nasdaq ,Citigroup ,Unity Biotechnology Company Profile ,Capital Investment Advisors ,Unity Biotechnology ,Free Report ,Moderate Buy ,Sigma Investments ,Street Group ,Unity Biotechnology Daily ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.